Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Beta-blocker on Cardioprotective Effect of Remote Ischemic Conditioning
NCT03169426Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- May 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of carvedilol in myocardial infarction (MI) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Changes in infarct size of rat heart perfused with human dialysate at 24 hours. Started May 2017; status: completed.
02
Drugs
carvedilol
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT03169426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03169426.